These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35398707)

  • 1. Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States.
    Mehrpour O; Saeedi F; Hoyte C; Hadianfar A; Nakhaee S; Brent J
    Am J Emerg Med; 2022 Jun; 56():171-177. PubMed ID: 35398707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of decision tree with common machine learning models for prediction of biguanide and sulfonylurea poisoning in the United States: an analysis of the National Poison Data System.
    Mehrpour O; Saeedi F; Nakhaee S; Tavakkoli Khomeini F; Hadianfar A; Amirabadizadeh A; Hoyte C
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):60. PubMed ID: 37024869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.
    Asche CV; McAdam-Marx C; Shane-McWhorter L; Sheng X; Plauschinat CA
    Drugs Aging; 2008; 25(7):611-22. PubMed ID: 18582148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
    Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
    Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biguanide related lactic acidosis: incidence and risk factors.
    Aguilar C; Reza A; García JE; Rull JA
    Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral hypoglycemic agents.
    Ferner RE
    Med Clin North Am; 1988 Nov; 72(6):1323-35. PubMed ID: 3054355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
    Whitlock RH; Hougen I; Komenda P; Rigatto C; Clemens KK; Tangri N
    Mayo Clin Proc; 2020 Jan; 95(1):90-100. PubMed ID: 31902433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biguanide-associated lactic acidosis. Case report and review of the literature.
    Gan SC; Barr J; Arieff AI; Pearl RG
    Arch Intern Med; 1992 Nov; 152(11):2333-6. PubMed ID: 1444694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of biguanide in therapy of diabetes mellitus].
    Haupt E; Panten U
    Med Klin (Munich); 1997 Aug; 92(8):472-9, 505. PubMed ID: 9340472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin.
    von Mach MA; Gauer M; Meyer S; Omogbehin B; Schinzel H; Kann PH; Weilemann LS
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):51-6. PubMed ID: 16502763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.
    Luft D; Schmülling RM; Eggstein M
    Diabetologia; 1978 Feb; 14(2):75-87. PubMed ID: 344119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratherapeutic doses of sulfonylureas in diabetic patients: how much is too much?
    Cantrell FL; Clark RF
    Clin Toxicol (Phila); 2007; 45(5):482-4. PubMed ID: 17503251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
    Margolis DJ; Hoffstad O; Strom BL
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):753-9. PubMed ID: 18613215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents.
    Zullo AR; Dore DD; Gutman R; Mor V; Alvarez CA; Smith RJ
    J Am Med Dir Assoc; 2017 Oct; 18(10):879-884.e7. PubMed ID: 28676291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus.
    Lapane KL; Jesdale BM; Dubé CE; Pimentel CB; Rajpathak SN
    Diabetes Res Clin Pract; 2015 Aug; 109(2):411-9. PubMed ID: 26008723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of hypoglycemia in users of sulfonylureas.
    van Staa T; Abenhaim L; Monette J
    J Clin Epidemiol; 1997 Jun; 50(6):735-41. PubMed ID: 9250272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.